Schwab U.S. Large-Cap Value ETF (SCHV)

Key Metrics

TER 4.00% per year

Distribution policy Distributing

Fund size USD 15,640 M

Inception date December 11, 2009

Holdings 558

Fund currency USD

Fund domicile US

Provider Schwab

For full official fund details, factsheets, and holdings, visit schwabassetmanagement.com (opens in new tab).

Historical Return

Last updated: Jun 15, 2026

1 Year +26.5% +1.7% Div

3 Years (avg.) +15.5% +1.7% Div

5 Years (avg.) +8.4% +1.7% Div

Risk & Analysis Metrics

Last updated: Jun 15, 2026

Volatility

10.50% 1 Year

12.45% 3 Years

14.41% 5 Years

16.89% 10 Years

Max Drawdown

-7.24% 1 Year

-16.22% 3 Years

-21.15% 5 Years

-37.07% 10 Years

Sharpe Ratio

1.66 1 Year

0.82 3 Years

0.32 5 Years

0.33 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026

	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
2011	-0.3%	4.9%	11.1%	10.7%	7.6%	8.8%	9.3%	6.7%	8.3%	7.2%	8.7%	7.0%	7.0%	7.3%	7.7%
2012		10.3%	17.3%	14.6%	9.7%	10.7%	11.0%	7.7%	9.4%	8.1%	9.7%	7.7%	7.6%	7.9%	8.3%
2013			24.8%	16.8%	9.5%	10.8%	11.2%	7.3%	9.3%	7.8%	9.6%	7.5%	7.3%	7.7%	8.1%
2014				9.3%	2.5%	6.5%	8.0%	4.1%	6.9%	5.6%	7.8%	5.7%	5.7%	6.2%	6.8%
2015					-3.8%	5.1%	7.6%	2.8%	6.4%	5.0%	7.6%	5.2%	5.4%	5.9%	6.6%
2016						14.7%	13.8%	5.1%	9.1%	6.9%	9.7%	6.6%	6.6%	7.1%	7.7%
2017							12.9%	0.6%	7.3%	5.0%	8.7%	5.3%	5.4%	6.1%	7.0%
2018								-10.3%	4.6%	2.5%	7.6%	3.8%	4.2%	5.2%	6.3%
2019									21.8%	9.5%	14.4%	7.7%	7.4%	8.0%	8.9%
2020										-1.5%	10.8%	3.4%	4.1%	5.5%	6.8%
2021											24.7%	5.9%	6.0%	7.3%	8.6%
2022												-10.1%	-2.2%	2.1%	4.9%
2023													6.3%	8.7%	10.4%
2024														11.2%	12.6%
2025															13.9%

Distributions

*by ETF Portfolio Weight Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%

1y 3y N/A N/A

0 - 5%

11%

1y 3y N/A N/A

5 - 10%

19%

1y 3y N/A N/A

10 - 15%

19%

1y 3y N/A N/A

15 - 20%

16%

1y 3y N/A N/A

20 - 30%

23%

1y 3y N/A N/A

30 - 40%

1y 3y N/A N/A

> 40%

1y 3y N/A N/A

P/E Ratio Distribution

< 0

1y 3y N/A N/A

0 - 10

1y 3y N/A N/A

10 - 15

11%

1y 3y N/A N/A

15 - 20

17%

1y 3y N/A N/A

20 - 25

19%

1y 3y N/A N/A

25 - 35

23%

1y 3y N/A N/A

35 - 50

13%

1y 3y N/A N/A

> 50

11%

1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation

N/A

Undervalued

> 60%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

15 - 30%

1y 3y N/A N/A

Fair (±15%)

1y 3y N/A N/A

Overvalued

15 - 30%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

> 60%

1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap

0.0%

1y 3y N/A N/A

Small Cap

0.0%

1y 3y N/A N/A

Mid Cap

2.0%

1y 3y N/A N/A

Large Cap

60.8%

1y 3y N/A N/A

Mega Cap

37.1%

1y 3y N/A N/A

Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in portfolio

Last updated: Jun 21, 2026

Market
Average

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$233B	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	1.89%	2.03%
Beta Indicates the relationship between the price performance of a share and the market.	0.86	-
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	31.73	28.29
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-91.08	-
Profitable Companies	97%	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	29.73	14.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	5.09	8.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	6.31	10.72

Market
Average

Enterprise Value to EBIT Enterprise Value divided by EBIT	25.28	21.15
Enterprise Value to Revenue Enterprise value divided by revenue	5.93	8.72
Total Debt to Enterprise Value Total debt divided by enterprise value	0.21	0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	0.83	0.33
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	15.82%	-6.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	+18.9%	-117.9%
Return on Equity Equity divided by market cap.	20.35%	1.23%
Return on Assets Indicates a company's profitability in relation to its total assets.	7.65%	3.29%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	13.54%	3.31%

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

Total Investment

Weight

Berkshire Hathaway Inc. - Ordinary Shares - Class A

BRK.A - Management of Companies and Enterprises

Market Cap

P/E Ratio

Dividends

Total Investment $488.17M

Weight 3.12%

Loading details…

JPMorgan Chase & Co.

JPM - Financial Services

Market Cap $871.43B

P/E Ratio 15.4

Dividends 1.8%

Total Investment $430.99M

Weight 2.76%

Loading details…

Exxon Mobil Corp.

XOM - Manufacturing

Market Cap $571.22B

P/E Ratio 22.8

Dividends 3.0%

Total Investment $339.06M

Weight 2.17%

Loading details…

Johnson & Johnson

JNJ - Manufacturing

Market Cap $549.78B

P/E Ratio 26.5

Dividends 2.3%

Total Investment $315.56M

Weight 2.02%

Loading details…

Walmart Inc

WMT - Retail Trade

Market Cap $932.53B

P/E Ratio 40.5

Dividends 0.8%

Total Investment $295.81M

Weight 1.89%

Loading details…

Micron Technology Inc.

MU - Manufacturing

Market Cap $1.28T

P/E Ratio 52.9

Dividends 0.0%

Total Investment $244.03M

Weight 1.56%

Loading details…

Abbvie Inc

ABBV - Manufacturing

Market Cap $382.74B

P/E Ratio 106.2

Dividends 3.1%

Total Investment $216.25M

Weight 1.38%

Loading details…

Procter & Gamble Co.

PG - Manufacturing

Market Cap $350.17B

P/E Ratio 21.8

Dividends 2.8%

Total Investment $205.98M

Weight 1.32%

Loading details…

Home Depot, Inc.

HD - Retail Trade

Market Cap $333.32B

P/E Ratio 23.7

Dividends 2.8%

Total Investment $199.8M

Weight 1.28%

Loading details…

Chevron Corp.

CVX - Manufacturing

Market Cap $345.8B

P/E Ratio 30.0

Dividends 4.0%

Total Investment $186.36M

Weight 1.19%

Loading details…

Caterpillar Inc.

CAT - Manufacturing

Market Cap $454.11B

P/E Ratio 48.9

Dividends 0.6%

Total Investment $183.27M

Weight 1.17%

Loading details…

Bank Of America Corp.

BAC - Finance and Insurance

Market Cap $398.83B

P/E Ratio 13.7

Dividends 2.0%

Total Investment $176.5M

Weight 1.13%

Loading details…

Coca-Cola Co

KO - Manufacturing

Market Cap $341.57B

P/E Ratio 24.9

Dividends 2.6%

Total Investment $166.47M

Weight 1.06%

Loading details…

Cisco Systems, Inc.

CSCO - Manufacturing

Market Cap $471.16B

P/E Ratio 39.6

Dividends 1.4%

Total Investment $165.09M

Weight 1.06%

Loading details…

Merck & Co Inc

MRK - Manufacturing

Market Cap $281.24B

P/E Ratio 31.5

Dividends 3.0%

Total Investment $162.03M

Weight 1.04%

Loading details…

Applied Materials Inc.

AMAT - Manufacturing

Market Cap $489.96B

P/E Ratio 57.7

Dividends 0.3%

Total Investment $156.37M

Weight 1.00%

Loading details…

Lam Research Corp.

LRCX - Manufacturing

Market Cap $486.52B

P/E Ratio 72.5

Dividends 0.3%

Total Investment $154.88M

Weight 0.99%

Loading details…

Philip Morris International Inc

PM - Manufacturing

Market Cap $278.05B

P/E Ratio 25.1

Dividends 3.2%

Total Investment $153.33M

Weight 0.98%

Loading details…

RTX Corp

RTX - Manufacturing

Market Cap $249.94B

P/E Ratio 34.5

Dividends 1.5%

Total Investment $143.22M

Weight 0.92%

Loading details…

Goldman Sachs Group, Inc.

GS - Finance and Insurance

Market Cap $323.49B

P/E Ratio 19.8

Dividends 1.6%

Total Investment $135.92M

Weight 0.87%

Loading details…

United States	96.6%
Ireland	1.9%
Switzerland	0.6%
United Kingdom	0.3%
Netherlands	0.2%
Bermuda	0.2%
Cayman Islands	0.1%
Other	0.1%
Sweden	0.0%
Other	0.0%

Manufacturing	43.8%
Finance and Insurance	15.8%
Retail Trade	6.1%
Information	5.5%
Utilities	4.8%
Transportation and Warehousing	3.5%
Financial Services	3.4%
Management of Companies and Enterprises	3.4%
Mining, Quarrying, and Oil and Gas Extraction	2.7%
Professional, Scientific, and Technical Services	2.0%
Accommodation and Food Services	1.1%
Wholesale Trade	1.0%
Administrative and Support and Waste Management and Remediation Services	0.8%
Real Estate and Rental and Leasing	0.5%
Construction	0.4%
Health Care and Social Assistance	0.4%
Healthcare	0.4%
Public Administration	0.2%
Arts, Entertainment, and Recreation	0.1%
Other Services (except Public Administration)	0.1%
Technology	0.1%
Finance	0.1%
Consumer Defensive	0.0%
Communication Services	0.0%
Other	3.5%

Key Metrics

Compare similar ETFs

Historical Return

Risk & Analysis Metrics

Volatility

Max Drawdown

Sharpe Ratio

Return Triangle (Heatmap)

Distributions

Profit Margin Distribution

P/E Ratio Distribution

Discounted Cash Flow

Market Cap Size Distribution

Portfolio Concentration

Latest News

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

The Portfolio That Gets You a Waterfront Condo in Miami Beach

Average metrics of all companies in portfolio

Sectors

Countries